Quadruplet Therapy May Be the New Frontline SOC in Multiple Myeloma.
- Published in:
- Oncology (08909091), 2024, v. 38, n. 8, p. 317
- By:
- Publication type:
- Article
Works matching IS 08909091 AND DT 2024 AND VI 38 AND IP 8
Results: 6
1
2
Expert Commentary on the Product Profile of Tislelizumab in Advanced Esophageal Cancer [including commentary by Krystal Preston].
- Published in:
- Oncology (08909091), 2024, v. 38, n. 8, p. 315
- By:
- Publication type:
- Article
3
Navigating a Paradigm Shift Venetoclax Treatment Redefines Landscape of Acute Myeloid Leukemia.
- Published in:
- Oncology (08909091), 2024, v. 38, n. 8, p. 311, doi. 10.46883/2024.25921025
- By:
- Publication type:
- Article
4
AI Use May Improve Treatment Outcomes in Prostate Cancer.
- Published in:
- Oncology (08909091), 2024, v. 38, n. 8, p. 309
- By:
- Publication type:
- Article
5
Epcoritamab in Relapsed/Refractory Follicular Lymphoma.
- Published in:
- Oncology (08909091), 2024, v. 38, n. 8, p. 306
- Publication type:
- Article
6
Exercise Treatment as Part of Multidisciplinary Whole Person Care in Oncology.
- Published in:
- Oncology (08909091), 2024, v. 38, n. 8, p. 305
- By:
- Publication type:
- Article